Yuda, S., Maruyama, D., Maeshima, A. M., Makita, S., Kitahara, H., Miyamoto, K., . . . Tobinai, K. (2016). Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era. Ann Hematol.
Chicago Style CitationYuda, Sayako, et al. "Influence of the Watch and Wait Strategy On Clinical Outcomes of Patients With Follicular Lymphoma in the Rituximab Era." Ann Hematol 2016.
Cita MLAYuda, Sayako, et al. "Influence of the Watch and Wait Strategy On Clinical Outcomes of Patients With Follicular Lymphoma in the Rituximab Era." Ann Hematol 2016.
Atenció: Aquestes cites poden no estar 100% correctes.